Back to mobile site

Zafgen (ZFGN) Learns of Death in Beloranib Phase 3

October 14, 2015 12:27 PM EDT Send to a Friend
Zafgen (NASDAQ: ZFGN) is on watch after shares were halted ahead of a news release made early Wednesday afternoon.In the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login